In this study, we demonstrated that bortezomib, a protease inhibitor, inhibited the nuclear translocation of NF-κB in colonic epithelial cells by suppressing the degradation of IκBα and and contributed to an improvement in DSS colitis. The gene discussed is NFKB1; the disease is colitis.